Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 91723

7 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
February 21, 2023
Product types
Device
Classifications
Class II
Statuses
Ongoing
Recalling firm wording
Entopsis , Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Device Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
  • openFDA Device Recall event_date_initiated coverage June 01, 1997–June 30, 2026

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

7 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

device · product 1 of 7

PCRopsis BCSNano (1mL), REF 2276001; nucleic acid extraction from a variety of biological samples

Z-1295-2023
Recall number
Z-1295-2023
Initiated
February 21, 2023
Classification
Class II
Status
Ongoing
Recalling firm
Entopsis , Inc.
Quantity
3 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Presence of misleading label statements on the product label.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Presence of misleading label statements on the product label.

Code information

Lot number 3, Exp. 11/2023

Distribution pattern

Nationwide and Canada, UK, Portugal, England, Spain, England , Germany, Brazil, Denmark, KOR, South Korea, Colombia, Lithuania

device · product 2 of 7

PCRopsis Reagent Buccal, IVD, REF 282001; Extraction-free PCR from bucca; swabs (no transport medium) ,nucleic acid extraction from a variety of biological samples

Z-1296-2023
Recall number
Z-1296-2023
Initiated
February 21, 2023
Classification
Class II
Status
Ongoing
Recalling firm
Entopsis , Inc.
Quantity
6 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Presence of misleading label statements on the product label.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Presence of misleading label statements on the product label.

Code information

Lot number 4, Exp. 08/2023

Distribution pattern

Nationwide and Canada, UK, Portugal, England, Spain, England , Germany, Brazil, Denmark, KOR, South Korea, Colombia, Lithuania

device · product 3 of 7

PCRopsis Activator: a) 1.5mL, REF 228001; b) 0.5mL,REF 228002; nucleic acid extraction from a variety of biological samples

Z-1297-2023
Recall number
Z-1297-2023
Initiated
February 21, 2023
Classification
Class II
Status
Ongoing
Recalling firm
Entopsis , Inc.
Quantity
52 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Presence of misleading label statements on the product label.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Presence of misleading label statements on the product label.

Code information

a) REF 282001: Lot Numbers: 3, Exp. 05/2023; 4, Exp. 07/2023; b) REF 228002: Lot Numbers: 3, Exp. 05/2023; 4, Exp. 07/2023; 5, Exp. 04/2023

Distribution pattern

Nationwide and Canada, UK, Portugal, England, Spain, England , Germany, Brazil, Denmark, KOR, South Korea, Colombia, Lithuania

device · product 4 of 7

PCRopsis Lysis Beads, IVDD: a) 25 tubes , REF 597000; b) 25 tubes, REF 597825; c) 50 tubes, REF 597850; d) 25 grams, REF 5970025; e) 1000 kilogram, REF 5971000; coated beads that facilitate lysis of microorganisms; nucleic acid extraction from a variety of biological samples

Z-1298-2023
Recall number
Z-1298-2023
Initiated
February 21, 2023
Classification
Class II
Status
Ongoing
Recalling firm
Entopsis , Inc.
Quantity
363 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Presence of misleading label statements on the product label.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Presence of misleading label statements on the product label.

Code information

a) REF 597000, Lot Numbers: 2, Exp. 05/2024; 3, Exp. 6024; b) REF 597825, Lot Numbers: 5, Exp. 06/2024; c) REF 597850, Lot Numbers: 2, Exp. 05/2024; d) REF 5970025, Lot Numbers: 2, Exp. 05/2024; 3, Exp. 06/2024; 4, Exp. 06/2024; 5, Exp. 06/2024; e) REF 5971000, Lot Numbers: 4, Exp. 06/2024

Distribution pattern

Nationwide and Canada, UK, Portugal, England, Spain, England , Germany, Brazil, Denmark, KOR, South Korea, Colombia, Lithuania

device · product 5 of 7

PCRopsis Reagent RVD with RVD Enhancer: a) 1 mL, VALIDATION USE ONLY, REF 78336001; b) 25 mL, REF 78336025; c) 100 mL, REF 78336100; Extraction-free PCR from saliva, urine, &swab specimens in transport medium, nucleic acid extraction from a variety of biological samples

Z-1299-2023
Recall number
Z-1299-2023
Initiated
February 21, 2023
Classification
Class II
Status
Ongoing
Recalling firm
Entopsis , Inc.
Quantity
397 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Presence of misleading label statements on the product label.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Presence of misleading label statements on the product label.

Code information

a) REF 78336001, Lot Numbers: 18, Exp. 05/2023; 20, Exp. 07/2023; 21, Exp. 07/2023; b) REF 78336025, Lot Numbers: 18, Exp. 05/2023; 20, Exp. 07/2023; 21, Exp. 07/2023; c) REF 78336100, Lot Numbers: 21, Exp. 07/2023

Distribution pattern

Nationwide and Canada, UK, Portugal, England, Spain, England , Germany, Brazil, Denmark, KOR, South Korea, Colombia, Lithuania

device · product 6 of 7

PCRopsis Reagent RVD-RT, IVD: a) 1 mL, REF 78378001; b) 25 mL, REF 78378025; c) 100 mL, REF 78378100; Extraction-free PCR at room temperature; nucleic acid extraction from a variety of biological samples

Z-1300-2023
Recall number
Z-1300-2023
Initiated
February 21, 2023
Classification
Class II
Status
Ongoing
Recalling firm
Entopsis , Inc.
Quantity
97 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Presence of misleading label statements on the product label.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Presence of misleading label statements on the product label.

Code information

a) REF 78378001, Lot Numbers: 4, Exp. 02/2023; 7, Exp. 07/2023; b) REF 78378025, Lot Numbers: 6, Exp. 06/2023; c) REF 78378100, Lot Numbers: 7, Exp. 07/2023

Distribution pattern

Nationwide and Canada, UK, Portugal, England, Spain, England , Germany, Brazil, Denmark, KOR, South Korea, Colombia, Lithuania

device · product 7 of 7

PCRopsis Support: a) 1 mL, REF 787001; b) 0.25 mL, REF 787002; c) 25 uL, REF 787003; Improves the functionality of PCRopsis regents for select applications; nucleic acid extraction from a variety of biological samples

Z-1301-2023
Recall number
Z-1301-2023
Initiated
February 21, 2023
Classification
Class II
Status
Ongoing
Recalling firm
Entopsis , Inc.
Quantity
94 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Presence of misleading label statements on the product label.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Presence of misleading label statements on the product label.

Code information

a) REF 787001, Lot Numbers: 4, Exp. 05/2023; b) REF 787002, Lot Numbers: 4, Exp. 05/2023; 5, Exp. 07/2023; c) REF 787003, Lot Numbers: 5 Exp. 07/2023

Distribution pattern

Nationwide and Canada, UK, Portugal, England, Spain, England , Germany, Brazil, Denmark, KOR, South Korea, Colombia, Lithuania

Field note

Send feedback

We'll only use this to respond to your feedback.